Delivery Device Patents on GLP-1 Receptor Agonists

被引：0
|
作者：
Alhiary, Rasha [1 ]
Gabriele, Sarah [1 ]
Kesselheim, Aaron S. [1 ]
Tu, S. Sean [2 ]
Feldman, William B. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA
[2] West Virginia Univ, Coll Law, Morgantown, WV USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 331卷 / 09期
关键词：
D O I：
10.1001/jama.2024.0919
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study analyzed the US Food and Drug Administration-listed patents on glucagon-like peptide 1 (GLP-1) receptor agonists to determine their claim characteristics and the potential barriers they pose to generic entry.
引用
收藏
页码：794 / 796
页数：3
相关论文
共 50 条
  • [21] The Cautious Promise of GLP-1 Receptor Agonists
    Dauterive, Rachel S.
    OCHSNER JOURNAL, 2024, 24 (03): : 165 - 166
  • [22] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [23] The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
    Silvia Tempia Valenta
    Alba Nicastri
    Federica Perazza
    Federica Marcolini
    Valentina Beghelli
    Anna Rita Atti
    Maria Letizia Petroni
    Current Treatment Options in Psychiatry, 2024, 11 (4) : 310 - 357
  • [24] Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
    Liu, Qiyuan Keith
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [25] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [26] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    DIABETOLOGIA, 2017, 60 : S393 - S393
  • [27] The Effect of GLP-1 Receptor Agonists on Bowel Preparation
    Mahmood, Sabah
    Ozminkowski, Erin
    Sakiri, Ahmet
    Aqeel, Ammar
    Abbasi, Abu Fahad
    Andersen, William
    Zhan, Weihai
    Khan, Naser
    Hamoudah, Thayer
    Dawood, Altaf
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S360 - S361
  • [28] GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    Bezin, Julien
    Gouverneur, Amandine
    Penichon, Marine
    Mathieu, Clement
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    DIABETES CARE, 2023, 46 (02) : 384 - 390
  • [29] Why are GLP-1 receptor agonists in short supply?
    Bailey, Clifford J.
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 72 - 72
  • [30] Mapping the effectiveness and risks of GLP-1 receptor agonists
    Xie, Yan
    Choi, Taeyoung
    Al-Aly, Ziyad
    NATURE MEDICINE, 2025, : 951 - 962
12345